Evidence map›Paper›PMID 42146949›Full record

ReviewRomanian journal of ophthalmology

A Network Biology Framework for Exploring Molecular Mechanisms in Cystoid Macular Edema.

Mehrdad Motamed Shariati

Abstract readReview
In one paragraph

Review in Romanian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mehrdad Motamed ShariatiEye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To explore the molecular mechanisms underlying cystoid macular edema (CME) through protein-protein interaction (PPI) network analysis, identifying key regulatory proteins, functional modules, and enriched biological pathways relevant to its pathogenesis. Methods: A curated list of 18 CME-associated human proteins was compiled through a literature review, including inflammatory cytokines, angiogenic factors, and regulators of vascular permeability. High-confidence PPI data were obtained from the STRING database (confidence score ≥ 0.700) and visualized as an undirected graph using NetworkX in Python. Centrality metrics (degree, betweenness, closeness, eigenvector), Louvain modularity analysis, and functional enrichment (GO: BP, KEGG, Reactome) were performed using GSEAPY and Enrichr to identify topologically and biologically important nodes and clusters. Results: The final network consisted of 91 nodes and 217 edges, with a graph density of 0.0505 and an average clustering coefficient of 0.0554. ANGPT2, FLT1, KDR, TNF, and VEGFA appeared as central hub proteins across multiple centrality measures. Louvain clustering identified eight distinct functional communities, including inflammatory mediators, angiogenic signaling components, and tight junction regulators. Enrichment analyses showed significant involvement of cytokine-mediated signaling, endothelial cell migration, the AGE-RAGE pathway, TNF signaling, and interleukin-4/10/13 signaling, highlighting the dual roles of angiogenesis and inflammation in CME. Discussion: The findings of this study highlight the intricate network of molecular mechanisms underlying cystoid macular edema (CME), with particular emphasis on angiogenesis, inflammation, and vascular permeability. The identification of key regulatory proteins such as ANGPT2, FLT1, and TNF underscores the complexity of CME pathogenesis, which involves both vascular and inflammatory pathways. Conclusions: CME is driven by a complex, modular molecular network involving inflammation, vascular remodeling, and cytokine signaling. ANGPT2, FLT1, TNF, and IL6 are key regulatory proteins and potential therapeutic targets. This systems biology approach offers a comprehensive framework for discovering new insights and guiding personalized treatment strategies in CME.

Indexed as

Macular EdemaProtein Interaction MapsAngiogenic ProteinsCapillary PermeabilityCell MovementCytokinesEndothelial CellsHumansMacula LuteaProtein Interaction MappingSignal TransductionSystems BiologyTight JunctionsAngiogenic ProteinsCytokinesAKT1 = AKT Serine/Threonine Kinase 1AKT2 = AKT Serine/Threonine Kinase 2angiogenesisANGPT2ANGPT2 = Angiopoietin-2Apoptosis RegulatorAQP4 = Aquaporin 4BAX = BCL2 Associated XBCL2 = BCL2 Apoptosis RegulatorCASP3 = Caspase 3CASP9 = Caspase 9CCL2 = C-C Motif Chemokine Ligand 2 (MCP-1)CCL5 = C-C Motif Chemokine Ligand 5 (RANTES)CCR2 = C-C Motif Chemokine Receptor 2CDH5 = Cadherin 5 (VE-Cadherin)CLDN5 = Claudin 5CXCL10 = C-X-C Motif Chemokine Ligand 10CXCL8 = C-X-C Motif Chemokine Ligand 8 (IL-8)CXCL9 = C-X-C Motif Chemokine Ligand 9CYBA = Cytochrome B-245 Alpha Chaincystoid macular edemaEDN1 = Endothelin 1enrichment analysisEPO = ErythropoietinERK1 = Extracellular Signal-Regulated Kinase 1 (MAPK3)ERK2 = Extracellular Signal-Regulated Kinase 2 (MAPK1)FGF1 = Fibroblast Growth Factor 1FGF2 = Fibroblast Growth Factor 2FGFR1 = Fibroblast Growth Factor Receptor 1FGFR2 = Fibroblast Growth Factor Receptor 2FLT1 = Fms Related Tyrosine Kinase 1 (VEGFR-1)FOXO1 = Forkhead Box O1HIF1A = Hypoxia Inducible Factor 1 Subunit AlphaHMOX1 = Heme Oxygenase 1ICAM1 = Intercellular Adhesion Molecule 1ICAM2 = Intercellular Adhesion Molecule 2IFNG = Interferon GammaIL10 = Interleukin 10IL10RA = Interleukin 10 Receptor Subunit AlphaIL13 = Interleukin 13IL13RA1 = Interleukin 13 Receptor Subunit Alpha 1IL17A = Interleukin 17AIL18 = Interleukin 18IL1A = Interleukin 1 AlphaIL1B = Interleukin 1 BetaIL4 = Interleukin 4IL4R = Interleukin 4 ReceptorIL6 = Interleukin 6IL6R = Interleukin 6 ReceptorinflammationITGAM = Integrin Subunit Alpha MITGB2 = Integrin Subunit Beta 2JAK1 = Janus Kinase 1JAK2 = Janus Kinase 2JAM2 = Junctional Adhesion Molecule 2KDR = Kinase Insert Domain Receptor (VEGFR-2)MAP2K1 = Mitogen-Activated Protein Kinase Kinase 1MAPK1 = Mitogen-Activated Protein Kinase 1 (ERK2)MAPK3 = Mitogen-Activated Protein Kinase 3 (ERK1)MAPK8 = Mitogen-Activated Protein Kinase 8 (JNK1)MitochondrialMMP1 = Matrix Metallopeptidase 1MMP2 = Matrix Metallopeptidase 2MMP3 = Matrix Metallopeptidase 3MMP7 = Matrix Metallopeptidase 7MMP9 = Matrix Metallopeptidase 9NFKB1 = Nuclear Factor Kappa B Subunit 1NFKBIA = NFKB Inhibitor AlphaNF-κB SubunitNOS2 = Nitric Oxide Synthase 2 (Inducible)NOS3 = Nitric Oxide Synthase 3 (Endothelial)NOX4 = NADPH Oxidase 4OCLN = OccludinPDGFB = Platelet-Derived Growth Factor Subunit BPECAM1 = Platelet and Endothelial Cell Adhesion Molecule 1PI3KCA = Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit AlphaPLAT = Plasminogen ActivatorPLAU = Plasminogen ActivatorPRKCA = Protein Kinase C AlphaPRKCB = Protein Kinase C Betaprotein-protein interaction networkPTGS2 = Prostaglandin-Endoperoxide Synthase 2 (COX-2)RAC1 = Rac Family Small GTPase 1RELA = RELA Proto-OncogeneS1PR1 = Sphingosine-1-Phosphate Receptor 1SELE = Selectin ESELP = Selectin PSERPINE1 = Serpin Family E Member 1 (PAI-1)SOCS3 = Suppressor of Cytokine Signaling 3SOD2 = Superoxide Dismutase 2STAT3 = Signal Transducer and Activator of Transcription 3systems biologyTGFB1 = Transforming Growth Factor Beta 1TGFBR1 = Transforming Growth Factor Beta Receptor 1TGFBR2 = Transforming Growth Factor Beta Receptor 2TIMP1 = TIMP Metallopeptidase Inhibitor 1TIMP2 = TIMP Metallopeptidase Inhibitor 2Tissue TypeTNF = Tumor Necrosis FactorTYK2 = Tyrosine Kinase 2UrokinaseVCAM1 = Vascular Cell Adhesion Molecule 1VEGFAVEGFA = Vascular Endothelial Growth Factor A

Identifiers

PMID42146949
PMCPMC13178748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.